2 completed, 1 not yet recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Not yet recruiting 1 |
Follow DTPP vaccine: new trials by email Literature Review of DTPP vaccine trials Research Report on DTPP vaccine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to Healthy Children 4 to 6 Years of Age MMRVNS vaccine, MMRV vaccine, DTaP-IPV vaccine - Measles, Mumps | Phase 3 | Not yet recruiting | GlaxoSmithKline | 1860 | 2026-08-11 | 2026-08-03 |
| Duration of Protection: GSK DTaP Vaccines Infanrix, Pediarix, Kinrix - Diphtheria, Acellular Pertussis | Completed | GlaxoSmithKline | 1 | 2015-02-01 | 2015-11-02 | |
| Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age Priorix, M-M-R II, Kinrix - Measles-Mumps-Rubella | Phase 3 | Completed | GlaxoSmithKline | 4011 | 2012-06-21 | 2019-11-25 |
Measles (2) · Mumps (2) · Chickenpox (1) · Diphtheria (1) · Rubella (1) · Tetanus (1)
GlaxoSmithKline (3)
Taiwan (2) · United States (2) · Argentina (1) · Finland (1) · Italy (1) · Puerto Rico (1) · South Korea (1)
2025 (1)